BMO Reduces Peabody Target, Regeneron Progressing, Edwards Lifesciences Top Pick, Dick’s on JPM Focus List

Peabody Energy Corp.(NYSE:BTU): BMO Capital reduced its target on Peabody Energy after the company provided significantly lower than expected Q1 EPS guidance. However, the firm reiterates an Outperform rating on the stock.

G-III Apparel Group, Ltd.(NASDAQ:GIII): Brean Murray lowered its price target on G-III Apparel citing continually warmer winter weather and the highly promotinal outerwear environmnet. The firm maintains its Buy rating and believes the company is well positioned for what should be a strong dress and handbag cycle.

Regeneron Pharmaceuticals, Inc.(NASDAQ:REGN): After meeting with Regeneron’s management, BMO Capital believes that management’s feedback indicates that the company’s launch of EYLEA is going well. The firm also believes that the company is making significant progress with its pipeline, and it maintains an Outperform rating on the stock.

Edwards Lifesciences Corp.(NYSE:EW): After Edwards announced better than expected data from a portion of its trial of Sapien using the transapical, or TA, approach, RBC Capital believes that the data was “excellent.” The firm thinks the data should ease investors’ fears about the safety of Sapien, and should help obtain FDA approval of Sapien for surgery eligible patients. The firm maintains a Top Pick rating on the stock.

Dick’s Sporting Goods Inc.(NYSE:DKS): JP Morgan added Dick’s Sporting to its Focus List on expectations the company is well positioned in 2012. The firm raised its price target for shares to $50 from $45 and keeps an Overweight rating on the stock.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

To contact the reporter on this story: Derek Hoffman at

To contact the editor responsible for this story: Damien Hoffman at